Huawei has marked a major step towards metabolic tracking, announcing a non-invasive diabetes risk assessment tool for its Watch GT 6 Pro.

Medical, Inc., a medical technology manufacturer specializing in compression therapy systems that treat peripheral vascular disorders, today announced the launch of the U.S. Food and Drug ...

Doctoral students work hand-in-hand with faculty researchers on advances such as a “band-aid” for the heart, non-invasive ...

With careful selection, same-day hospital discharge was found to be feasible and safe in around one-fifth of patients ...

With careful selection, same-day hospital discharge was found to be feasible and safe in around one-fifth of patients undergoing transcatheter aortic valve implantation in a study presented today at ...

Top Delhi vascular experts warn that prolonged sitting, poor hydration and unhealthy lifestyle habits are quietly damaging ...

With careful selection, same-day hospital discharge was found to be feasible and safe in around one-fifth of patients undergoing transcatheter aortic ...

Hypertension is the leading risk factor for cardiovascular disease, the most common cause of death worldwide. Less than half the people with high blood pressure are aware of their diagnosis, and only ...

AngioDynamics, Inc. , a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, ...

Clerio Vision, Inc., a developer of next-generation laser-based vision correction platforms, today announced that it will be delivering two key presentations at the upcoming annual Wavefront Congress, ...

Premenopausal women presenting with acute coronary syndrome (ACS) are a unique and often underrecognized patient population. Although they are traditionally considered at lower cardiovascular risk ...

Late-breaking KEYNOTE-B15 data show KEYTRUDA ® (pembrolizumab) plus Padcev ® (enfortumab vedotin-ejfv) significantly improved event-free survival, overall survival and pathologic complete response ...